Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isaacs

Showing results (201-210 of 240) with videos related to

Pageof 24
Sort By:
Journal of Neurosurgery. Pediatrics|February 7, 2025
Reimagining durability of hydrocephalus treatment using conditional survivalAaron M Yengo-Kahn, John C Wellons, Hailey Jensen, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral SclerosisPuja R Mehta, Tomas Solomon, Sarah Pickles, et al.
Science (New York, N.Y.)|August 9, 2014
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteinsSarah Mizielinska, Sebastian Grönke, Teresa Niccoli, et al.
Iscience|April 29, 2021
Immune activation during <i>Paenibacillus</i> brain infection in African infants with frequent cytomegalovirus co-infectionAlbert M Isaacs, Sarah U Morton, Mercedeh Movassagh, et al.
Brain : a Journal of Neurology|September 13, 2011
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degenerationJonathan D Rohrer, Tammaryn Lashley, Jonathan M Schott, et al.
Journal for Immunotherapy of Cancer|March 3, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)Emily K Ninmer, Gina R Petroni, Brian R Gastman, et al.
Nature Neuroscience|February 25, 2025
Neuronal polyunsaturated fatty acids are protective in ALS/FTDAshling Giblin, Alexander J Cammack, Niek Blomberg, et al.
Journal of Neurosurgery. Pediatrics|January 23, 2026
Clinical presentation of hydrocephalus following pre- and postnatal myelomeningocele repair: a Hydrocephalus Clinical Research Network studySasidhar Karuparti, Hailey Jensen, Ron W Reeder, et al.
Nature Neuroscience|March 7, 2025
Author Correction: Neuronal polyunsaturated fatty acids are protective in ALS/FTDAshling Giblin, Alexander J Cammack, Niek Blomberg, et al.
Nature Neuroscience|December 19, 2018
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression ratesFlorent Laferrière, Zuzanna Maniecka, Manuela Pérez-Berlanga, et al.
Pageof 24

Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
Journal of Neurosurgery. Pediatrics|February 7, 2025
Reimagining durability of hydrocephalus treatment using conditional survivalAaron M Yengo-Kahn, John C Wellons, Hailey Jensen, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral SclerosisPuja R Mehta, Tomas Solomon, Sarah Pickles, et al.
Science (New York, N.Y.)|August 9, 2014
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteinsSarah Mizielinska, Sebastian Grönke, Teresa Niccoli, et al.
Iscience|April 29, 2021
Immune activation during <i>Paenibacillus</i> brain infection in African infants with frequent cytomegalovirus co-infectionAlbert M Isaacs, Sarah U Morton, Mercedeh Movassagh, et al.
Brain : a Journal of Neurology|September 13, 2011
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degenerationJonathan D Rohrer, Tammaryn Lashley, Jonathan M Schott, et al.
Journal for Immunotherapy of Cancer|March 3, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)Emily K Ninmer, Gina R Petroni, Brian R Gastman, et al.
Nature Neuroscience|February 25, 2025
Neuronal polyunsaturated fatty acids are protective in ALS/FTDAshling Giblin, Alexander J Cammack, Niek Blomberg, et al.
Journal of Neurosurgery. Pediatrics|January 23, 2026
Clinical presentation of hydrocephalus following pre- and postnatal myelomeningocele repair: a Hydrocephalus Clinical Research Network studySasidhar Karuparti, Hailey Jensen, Ron W Reeder, et al.
Nature Neuroscience|March 7, 2025
Author Correction: Neuronal polyunsaturated fatty acids are protective in ALS/FTDAshling Giblin, Alexander J Cammack, Niek Blomberg, et al.
Nature Neuroscience|December 19, 2018
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression ratesFlorent Laferrière, Zuzanna Maniecka, Manuela Pérez-Berlanga, et al.
Pageof 24